Cricket Protein Bioavailability in Younger, Middle-Aged and Older Adults

NCT ID: NCT06906159

Last Updated: 2025-04-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-11

Study Completion Date

2025-03-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A global shift towards sustainable food sources is now emerging, largely due to the immense environmental pressure that comes from producing animal foods, particularly beef. Insects present a novel source of sustainable dietary protein due to their high protein content. This is particularly relevant for older adults, as protein becomes increasingly more important in later life. It helps to maintain muscle as we age, which is crucial for reducing frailty, falls and early mortality. We want to find out more about the digestion and absorption of insect protein in older people to see if it could be a beneficial source of protein to help maintain muscle. We are interested in the use of insect-based solid foods, especially the use of flour made from grounded whole crickets. We want to explore the digestibility of cricket protein compared to a commonly used animal alternative (whey protein) to find out if it can be efficiently absorbed and utilised within humans.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants are asked to fast overnight and come in the following day for one of two visits where they are given a standardised breakfast muffin containing either cricket protein or whey protein (250-300 kcal; approx. 12% fat, 45% carbohydrates including 10% sugars, 35% protein, 0.4% salt and 6% fibre) after which they breathe into a test tube in 15-30 minute intervals for 4 hours. In addition to this, we collect a blood sample (10ml) every 15 minutes for the first hour and then every 30 minutes for the next 3 hours (110ml of blood in total per visit) so we can determine changes in blood amino acids, glucose and fat concentrations after eating the muffin. In total we only collect a small amount of blood. This method of blood collection is the same method used for a traditional blood test but to avoid repeated needle insertions we use a cannula which remains in the participant's arm for the duration of the visit so that only a single needle insertion is necessary.

The muffin contains a small amount of a natural fat called octanoic acid. The octanoic acid is enriched with carbon-13. This is a natural variant of carbon and is safe to use, even in babies and pregnant women. At the end of each test visit we ask participants to fill out a short questionnaire to ask about the taste of the muffins. Participants are required to repeat this whole process for a second visit in which they consume the other muffin.

The muffins are identical between the two test visits with the exception that one muffin is made with a milk-based protein (whey) whereas the other test muffin is made with an insect protein (cricket). The test muffins are similar in size, shape, and taste. Participants are randomised to a muffin condition in a crossover design. Participants are blinded to the muffin condition and only one member of the research team knows which muffin participants receive on which test visit but they are not present during the test visits. The researchers conducting the test visits do not know which muffin is being consumed by participants.

Participants are required to attend for 2 test visits each lasting approximately 5 hours. This takes place in the Clinical Investigation Unit (CIU) at the University of Surrey. On the day before each of the test visits participants are asked to arrive fasted for 12 hours overnight, refrain from strenuous exercise, alcohol, caffeine and food containing corn, broccoli, sugarcane, and tropical fruits (because of the type of natural carbon-13 they contain) the day before their visits.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cricket Protein Whey Protein

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Repeated measures randomised crossover design
Primary Study Purpose

OTHER

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
One member of the research team is in charge if blinding the muffins to 'A' and 'B'

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cricket muffin

Muffin made with cricket-derived protein powder

Group Type EXPERIMENTAL

Cricket protein

Intervention Type DIETARY_SUPPLEMENT

Muffins made with cricket-derived protein from house crickets (Acheta domesticus )

Whey muffin

Muffin made with whey protein powder

Group Type ACTIVE_COMPARATOR

Whey protein

Intervention Type DIETARY_SUPPLEMENT

Muffins made with whey protein

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cricket protein

Muffins made with cricket-derived protein from house crickets (Acheta domesticus )

Intervention Type DIETARY_SUPPLEMENT

Whey protein

Muffins made with whey protein

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy adult males and females in general good health, aged between 18 - 35 years, 40 - 55 years or over 65 years
* BMI between 18.5 and 35 kg/m2
* Stable weight for at least 3 months
* Volunteers must be able and willing to give informed written consent
* Volunteers must be able to eat egg
* Volunteers must be willing to provide blood samples

Exclusion Criteria

* Current or previous gastrointestinal conditions (e.g. Crohn's disease, Coeliac disease, Irritable Bowel Syndrome) - assessed via a health questionnaire
* Those with diabetes or other metabolic conditions - assessed via a health questionnaire
* Those taking food supplements which may impact digestion (e.g., digestive enzymes, probiotics, fibre supplements)
* Those smoking, using nicotine products (e.g., e-cigarettes, patches) or not abstained from these activities for more than 6 months - assessed via a health questionnaire
* Pregnant or lactating
* Volunteers with a high daily caffeine intake \> 300 mg/day (more than 5 cups of standard coffee per day)
* Drug or alcohol abuse in the last 2 years
* Those who are currently taking part in a clinical trial or another research study or have taken part within the last 3 months
* Those with food allergies, dietary intolerance or Coeliac disease - assessed via a health questionnaire
* Those following weight loss diets
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

HOP

UNKNOWN

Sponsor Role collaborator

University of Surrey

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

James Rutherford, MSc

Role: STUDY_DIRECTOR

University of Surrey

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Surrey

Guildford, Surrey, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CriProB

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Spoonable Bioavailability
NCT06733142 COMPLETED NA